By Julie A. Schneider, PhD; Jennifer J. Gao, MD; Donna R. Rivera, PharmD, MS; Martha B. Donoghue, MD; Gregory H. Reaman, MD, FASCO, Associate Director for Pediatric Oncology, OCE; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; Paul G. Kluetz, MD; Marc R. Theoret, MD; and Richard Pazdur, MD
/ December 25, 2021
OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Julie A. Schneider, PhD, Associate Director for Research Strategy and Partnerships, OCE; Jennifer J. Gao, MD,...